Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topotecan-induced bronchiolitis.

Colin C Edgerton1, Matthew Gilman, Bernard J Roth

  • 1Department of Internal Medicine, Madigan Army Medical Center, Tacoma, WA 98431, USA. colin.edgerton@nw.amedd.army.mil

Southern Medical Journal
|August 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary manifestations of chronic HPV infection in patients with recurrent respiratory papillomatosis.

The Lancet. Respiratory medicine·2022
Same author

Comparison of Baseline, Bone-Subtracted, and Enhanced Chest Radiographs for Detection of Pneumothorax.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2020
Same author

Feasibility and accuracy of CT-guided percutaneous needle biopsy of cavitary pulmonary lesions.

Diagnostic and interventional radiology (Ankara, Turkey)·2019
Same author

Trauma associated sleep disorder: A parasomnia induced by trauma.

Sleep medicine reviews·2017
Same author

Further Evidence for a Parasomnia Incited by Trauma.

Sleep·2016
Same author

A Comparative Analysis of Sleep Disordered Breathing in Active Duty Service Members with and without Combat-Related Posttraumatic Stress Disorder.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2015
Same journal

SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

Southern medical journal·2026
Same journal

Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

Southern medical journal·2026
Same journal

Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

Southern medical journal·2026
Same journal

Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

Southern medical journal·2026
Same journal

Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

Southern medical journal·2026
Same journal

Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

Southern medical journal·2026
See all related articles

Topotecan, an antitumor drug, can cause rare lung toxicity. This case study details obliterative bronchiolitis in a patient treated with topotecan for peritoneal carcinomatosis.

Area of Science:

  • Oncology
  • Pulmonology
  • Pharmacology

Background:

  • Topotecan hydrochloride is an antitumor agent that inhibits topoisomerase I.
  • It is utilized for treating metastatic ovarian cancer and as a second-line therapy for small-cell lung cancer.
  • Hematologic adverse events are the primary dose-limiting toxicities associated with topotecan.

Observation:

  • Lung toxicity is a rare adverse event reported in patients receiving topotecan.
  • This report details a case of a 61-year-old woman who developed respiratory symptoms while undergoing topotecan treatment.
  • The patient was receiving topotecan for peritoneal carcinomatosis.

Findings:

  • The patient presented with dyspnea, indicative of respiratory distress.
  • Radiographic imaging and pulmonary function tests revealed abnormalities consistent with obliterative bronchiolitis.

Related Experiment Videos

  • This suggests a potential link between topotecan therapy and the development of this specific lung pathology.

    • Implications:

    • This case highlights the importance of monitoring for pulmonary adverse events in patients treated with topotecan.
    • Obliterative bronchiolitis, though rare, should be considered in the differential diagnosis of lung toxicity in patients on topotecan.
    • Further investigation into the mechanisms of topotecan-induced lung injury may be warranted.